NCT05124457View on ClinicalTrials.gov

DETERMINE: Detemir vs NPH

PHASE2RecruitingINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Gestational DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

Insulin Detemir

Patients are to receive insulin detemir

DRUG

Insulin NPH

Patients are to receive insulin NPH

Trial Locations (1)

90069

RECRUITING

University of California, Los Angeles, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER